Drawing for LADER

USPTO serial 76429951

LADER

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
POWERS, ALEXANDER L
Law office
TMEG LAW OFFICE 101 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with LADER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael J. Bujold

MICHAEL J BUJOLD DAVIS & BUJOLD PLLC112 PLEASANT STCONCORD, NH 03301UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Alkaline metals, namely sodium potassium, lithium, caesium and rubidium for use in the manufacture of alkaline salts, electrodes and electrochemical cells; salts of alkaline metals for use in the manufacture of buffer solutions, solvents, crystals and electrochemical cells; chemical substances, namely, buffer solutions, proteins and modifications thereof, DNA and modification thereof, dyes, redox-active compounds and modifications thereof, namely quinones, ferrocenes, metal complexes, osmium complexes, chlorophylls, porphyrines and modifications thereof for use in laboratory analysis in the field of biotechnology, analytics, research, diagnostics, drug discovery, food manufacture, drug design, genomics, proteomics, molecular biology, manufacture of scientific compounds, manufacture of pharmaceutical compounds and electronics excluding for medical and veterinary purposes; baths for galvanizing; bacteria preparations, namely photosynthetic bacteria and E. coli preparations, for use in the fields of biotechnology, analytics, research, diagnostics, drug discovery, food manufacture, drug design, genomics, proteomics, molecular biology, manufacture of scientific compounds, manufacture of pharmaceutical compounds, electronics and the manufacture of electron transfer systems, dyes and redox active products excluding for medical and veterinary purposes; bacteriological preparations, namely preparations of photosynthetic bacteria and E. coli for use in the fields of biotechnology, analytics, research, diagnostic, drug discovery, food manufacture, drug design, genomics, proteomics, molecular biology, manufacture of scientific compounds, manufacture of pharmaceutical compounds, electronics and the manufacture of electron transfer systems, dyes and redox active products excluding for medical and veterinary purposes; benzene derivatives for use in the fields of biotechnology, analytics, research, diagnostics, drug discovery, food manufacture, drug design, genomics, proteomics, molecular biology, manufacture of scientific compounds, manufacture of pharmaceutical compounds and the manufacture of electron transfer systems, dyes and redox active products excluding for medical and veterinary purposes; biochemical catalysts for use in the fields of biotechnology, analytics, research, diagnostics, drug discovery, food manufacture, drug design, genomics, proteomics, molecular biology, manufacture of scientific compounds, manufacture of pharmaceutical compounds and electronics; biological preparations, namely peptides, proteins, nucleic acids and modified nucleic acids for use in laboratories, analytical instruments and for the manufacture of electron transfer systems, dyes and redox active products excluding for medical or veterinary purposes; chemical products for agricultural purposes, namely buffer solutions, proteins and modifications thereof, DNA and modifications thereof, dyes, redox-active compounds and modifications thereof, namely quiones, ferrocenes, metal complexes, osmium complexes, chlorophylls, porphrines and modifications thereof for use in the fields of biotechnology, analytics, research, diagnostics, food manufacture, genomics, proteomics, molecular biology, manufacture of scientific compounds excluding fungicides, herbicides, insecticides and preparations for destroying parasite; chemical products, namely buffer solutions, proteins and modifications thereof, DNA and modifications thereof dyes, redox-active compounds and modifications thereof, namely quionones, ferrocenes, metal complexes, osmium complexes, chlorophylls, phorphyrines and modifications thereof for scientific purposes in the fields of biotechnology, analytics, research, diagnostics, drug discovery, food manufacture, drug design, genomics, proteomics, molecular biology, manufacture of scientific compounds, manufacture of pharmaceutical compounds and electronics excluding for medical or veterinary purposes; detergents for use in manufacturing processes in the fields of biotechnology, analytics, research, diagnostics, drug discovery, food manufacture of scientific compounds,manufacture of pharmaceutical compounds and electronics; diagnostic preparations for scientific use in the fields of biotechnology, analytics, research, diagnostics, drug discovery, food manufacture, drug design, genomics, proteomics, molecular biology, manufacture of scientific compounds and manufacture of pharmaceutical compounds excluding for medical or veterinary purposes; salts of precious metals for use in electrochemical measurement units and for the manufacture of electrodes; graphite for use in electrochemical measurement units and for the manufacture of electrodes; biological preparations, namely peptides, proteins and modifications thereof, nucleic acids and modified nucleic acids for laboratory purposes in the fields of biotechnology, analytics, research, diagnostics, drug discovery, food manufacture, drug design, genomics, proteomics, molecular biology, manufacture of scientific compounds, manufacture of pharmaceutical compounds and electronics excluding for medical or veterinary purposes; photosensitive plates for use in the fields of ananlytics, research, diagnostics and electronics; protein as a raw material for laboratory purposes in the fields of biotechnology, analytics, research, diagnostics, drug discover, food manufacture, drug design, genomics, proeomic, molecular biology, manufacture of scientific compounds, manufacture of pharmaceutical compounds, electronics and the manufacture of electron transfer systems, dyes and redox active products; chemical reagents for scientific research in the fields of biotechnology, analytics, research, diagnostics, drug discovery, food manufacture, drug design, genomics, proteomics, molecular biology, manufacture of scientific compounds, manufacture of pharmaceutical compounds, electronics and the manufacture of electron transfer systems , dyes and reodx active products excluding medical or veterinary purposesACTIVE—
005Amino acids for use in medical diagnostics and development of pharmaceuticals; amino acids for veterinary diagnostics; medicines,namely antibodies, antibiotics, nucleic acids, vaccines, hormones and enzymes for human-medical purposes; medicines, namely antibodies, antibiotics, nucleic acids, vaccines, hormones and enzymes for veterinary purposes; medicines, namely antibodies, antibiotics, nucleic acids vaccines, hormones and enzymes for dental purposes; bacterial preparations for use in the medical or veterinary field, namely in medical diagnostics, medicines and development of pharmaceuticals; bacteriological preparations for use int he medical or veterinary field, anemly in medical diagnostics, medicines and development of pharmaceuticals; biological preparations for use in te medical field, namely in medical diagnostics, medicines and development of pharmaceuticals; biological preparations for veterinary diagnostics; chemcial-pharmaceutical preparations, namely DNA-chips; chemcial preparations, namely bufffer solutions, proteins and modifications thereof, DNA and modifications thereof, PCR Products, dyes, redox-active compounds and modifications thereof, namely quiones, ferrocenes, metal complexes, osmium complexes, chlorophylls, porphyrines and modifications thereof for use in medical diagnostics medicines and development of pharmaceticals; detergents for use in medical diagnostics and development of pharmaceutical; diagnostic preparations for use in medical diagnostics and development of pharmaceticuals; deooxyribonucleinic acid for use in medical diagnostics, medicines and development of pharmaceuticals; protein preparations for use in medical diagnostics, medicines and development of pharmaceuticals for medical purposes; enzymes for use in medical diagnostics, medicines and development of pharmaceuticals for medical purposes, enzymes for veterinary diagnostics; vaccines; nucleotides for use in medical diagnostics, medicines and development of pharmaceuticals; nucleotide derivatives for use in medical diagnostics, medicines and development of pharmaceuticalsACTIVE—
007Generators of electricity; electromechanical machines, namely potentiostates, current-charge-and voltage-measurements instruments for use in the chemical industry; labeler machines; electric current generators industrial robots; machines, namely vacuum pumps; packing machines; parts of machines, namely heat exchanges, heater, illuminating instrument, electrical measurement unitsACTIVE—
009Automatic machines for the synthesis of deoxyribonucleinic acid and derivative thereof; laboratory equipment, namely liquid sample handling equipment, liquid sample containers, micro titer plates, sample preparation equipment, DNA and protein detection apparatus, DNA and protein analysis apparatus, DNA Sequencer, equipment for cleaning and purification of liquids and biological material, bacteria and virus analysis apparatus, gene analysis apparauts for use in the fields of biotechnology, analytics, research, diagnostics, drug discovery, food manufacture, drug design, genomics, proteomics, molecular biology, manufacture of scientific compounds, manufacture of pharmaceutical compounds and electronics; food analysis apparatus, namely gene analysis apparatus and protein analysis apparatus; testing apparatus, namely gene testing apparatus and protein testing apparatus not for medical purposes; anodes; anticathodes; electricity indicators, namely current charge and voltage measuring instruments; incubators for bacteria culture; electric batteries; solar batteries; chemistry apparatus and instruments, namely analytical instruments, namely DNA and protein detection apparatus, DNA and protein analysis apparatus, DNA sequencer, bacteria and virus analysis apparatus, gene analysis; integrated silicon circuit chips; glass covered with and electrical conductor; semi-conductors; cathodes; optical condensers; electric contracts made of precious metal; laser, not medical purposes; electric conductors; connections, namely wires and molecular wires for electric lines; light conducting filaments, namely optical fibers; photometers; diaphragms for scientific apparatus; measuring apparatus, namely biochip-reader, fluorescence reader and electrochemical measuring apparatus; electric measuring devices, namely electrochemically measuring devices; microprocessors; optical apparatus and instruments, namely fluorescence reader, optical illumination instrument and optical biochip-reader; light conducting filaments; photovoltaic cells; electric switches; integrated circuits; probes for detection of chemical products for scientific purposes; voltmeters; bar code readers; electronic transistors; centrifugal separators for cleaning and purification of liquids and biological material for laboratory useACTIVE—
010Apparatus for use in medical analysis, namely diagnostic instruments, namely DNA and protein detection apparatus, DNA and protein analysis apparatus, DNA sequencer, bacteria and virus analysis apparatus, gene analysis apparatus; blood testing apparatus for the detection of gene sequences and proteins; diagnostic apparatus, namely gene analysis apparatus and protein analysis apparatus for medical purposes; electrodes for medical use; veterinary apparatus and instruments, namely gene analysis apparatus and protein analysis apparatusACTIVE—
042Chemical analyses; research in the field of bacteriology; bacteriological laboratory services; professional advice in the fields of bacteriology, biology, virology, chemistry, gene and protein analysis excluding business consulting; biological research; research in the field chemistry; chemical laboratory services; research in the field of genealogy; laboratory research in the field of cosmetics; writing of technical certificate for others; research and research and development in the fields of bacteriology, biology, virology and chemistry for otherACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Aug 15, 2007MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 15, 2007ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 17, 2007GNSIINQUIRY TO SUSPENSION E-MAILED—
Jan 17, 2007CNSISUSPENSION INQUIRY WRITTEN—
Jul 25, 2006TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 17, 2006CNSLLETTER OF SUSPENSION MAILED—
Jul 15, 2006CNSLSUSPENSION LETTER WRITTEN—
Jul 15, 2006ACECAMENDMENT FROM APPLICANT ENTERED—
Jun 5, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 5, 2006MAILPAPER RECEIVED—
Apr 26, 2006ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Apr 19, 2006ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jan 17, 2006CNSIINQUIRY AS TO SUSPENSION MAILED—
Jan 14, 2006CNSISUSPENSION INQUIRY WRITTEN—
Jul 14, 2005CNSLLETTER OF SUSPENSION MAILED—
Jul 14, 2005CNSLSUSPENSION LETTER WRITTEN—
Jul 14, 2005TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 11, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 11, 2005TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 10, 2005CNSIINQUIRY AS TO SUSPENSION MAILED—
Jan 8, 2005CNSISUSPENSION INQUIRY WRITTEN—
Jul 7, 2004CNSLLETTER OF SUSPENSION MAILED—
Jun 29, 2004TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 29, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 29, 2004ACECAMENDMENT FROM APPLICANT ENTERED—
Jun 29, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 29, 2004TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 8, 2004CNSIINQUIRY AS TO SUSPENSION MAILED—
Dec 11, 2003CFITCASE FILE IN TICRS—
Apr 29, 2003CNSLLETTER OF SUSPENSION MAILED—
Jan 21, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 21, 2003MAILPAPER RECEIVED—
Oct 22, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 30, 2002DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance